Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhuvanesh Singh

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Plos One|January 18, 2019
Mouse DCUN1D1 (SCCRO) is required for spermatogenetic individualizationGuochang Huang, Andrew J Kaufman, Russell J H Ryan, et al.
Journal of Medicinal Chemistry|March 17, 2018
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin NeddylationJared T Hammill, Deepak Bhasin, Daniel C Scott, et al.
Journal of the National Cancer Institute|November 20, 2003
Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patientsDavid I Kutler, Volkert B Wreesmann, Andy Goberdhan, et al.
Oral Oncology|December 17, 2013
A novel tumor: specimen index for assessing adequacy of resection in early stage oral tongue cancerPablo H Montero, Frank L Palmer, Andrew G Shuman, et al.
Cancer|January 9, 2014
Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinomaPablo H Montero, Changhong Yu, Frank L Palmer, et al.
Cancer Research|October 5, 2006
Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomasInderpal Sarkaria, Pornchai O-charoenrat, Simon G Talbot, et al.
Cancer Research|June 3, 2004
Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic markerVolkert B Wreesmann, Elizabeth M Sieczka, Nicholas D Socci, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2011
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancersLuc G T Morris, Barry S Taylor, Trever G Bivona, et al.
The Annals of Thoracic Surgery|October 30, 2004
SCCRO expression correlates with invasive progression in bronchioloalveolar carcinomaInderpal S Sarkaria, DuyKhanh Pham, Ronald A Ghossein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Molecular characteristics predict clinical outcomes: prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR geneNaiyer A Rizvi, Valerie Rusch, William Pao, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Plos One|January 18, 2019
Mouse DCUN1D1 (SCCRO) is required for spermatogenetic individualizationGuochang Huang, Andrew J Kaufman, Russell J H Ryan, et al.
Journal of Medicinal Chemistry|March 17, 2018
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin NeddylationJared T Hammill, Deepak Bhasin, Daniel C Scott, et al.
Journal of the National Cancer Institute|November 20, 2003
Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patientsDavid I Kutler, Volkert B Wreesmann, Andy Goberdhan, et al.
Oral Oncology|December 17, 2013
A novel tumor: specimen index for assessing adequacy of resection in early stage oral tongue cancerPablo H Montero, Frank L Palmer, Andrew G Shuman, et al.
Cancer|January 9, 2014
Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinomaPablo H Montero, Changhong Yu, Frank L Palmer, et al.
Cancer Research|October 5, 2006
Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomasInderpal Sarkaria, Pornchai O-charoenrat, Simon G Talbot, et al.
Cancer Research|June 3, 2004
Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic markerVolkert B Wreesmann, Elizabeth M Sieczka, Nicholas D Socci, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2011
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancersLuc G T Morris, Barry S Taylor, Trever G Bivona, et al.
The Annals of Thoracic Surgery|October 30, 2004
SCCRO expression correlates with invasive progression in bronchioloalveolar carcinomaInderpal S Sarkaria, DuyKhanh Pham, Ronald A Ghossein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Molecular characteristics predict clinical outcomes: prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR geneNaiyer A Rizvi, Valerie Rusch, William Pao, et al.
Pageof 15